Future therapies for heart failure.
The treatment of heart failure has changed as the understanding of the disease evolves. Heart failure remains the only cardiovascular disease that continues to rise in both incidence and prevalence, despite recent advances in treating symptoms and thwarting disease progression. Many opportunities exist for improving patient outcomes with pharmaceutical agents and technologies available now or in the near future. This article discusses recently approved drugs and devices and clinical trials that may affect the management of this challenging disease.
Trupp
Robin J
RJ
The Heart and Lung Research Institute, The Ohio State University 473 West 12th Avenue, Columbus, OH 43210, USA. trupp-1@medctr.osu.edu
Abraham
William T
WT
Lamba
Sumant
S
D002304:Cardiac Pacing, Artificial / Q000639:trends; D006348:Cardiac Surgical Procedures / Q000639:trends*; D002309:Cardiology / Q000639:trends*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D019468:Disease Management; D004232:Diuretics / Q000627:therapeutic use; D005544:Forecasting; D006333:Heart Failure / Q000453:epidemiology / Q000628:therapy*; D006353:Heart-Assist Devices / Q000639:trends; D006801:Humans; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014665:Vasodilator Agents / Q000627:therapeutic use
D002316:Cardiotonic Agents; D004232:Diuretics; D014665:Vasodilator Agents